Cytokinetics (CYTK) Q4 2021 Earnings

3NovConfirmed
Q1 2021
Q2 2021
Q3 2021
Q4 2021
-0.95
-0.7
-0.44
-0.19

Details

Expected EPS
-0.78
Actual EPS
-0.95
Surprise EPS
-0.17
Surprise Percent
+21.79%

Description

Cytokinetics (CYTK) has reported earnings of -0.95 per share for Q4 2021.

0 Comments

Share your thoughts